INGN (STOCKS)
Inogen Inc
$6.410000
+0.040000 (+0.63%)
Prev close: $6.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kevin R. M. Smith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $173.68M
- Employees
- 766
- P/E (TTM)
- -6.99
- P/B (TTM)
- 0.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.30 | $-0.29 | -0.0113 | -3.91% |
|
Dec 2025 (Q4)
|
$-0.26 | $-0.36 | +0.1046 | +28.69% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.22 | +0.0944 | +42.07% |
|
Jun 2025 (Q2)
|
$-0.15 | $-0.27 | +0.1220 | +44.85% |
Financial Statements
| Revenues | $351.50M |
| Benefits Costs and Expenses | $377.10M |
| Cost Of Revenue | $195.74M |
| Costs And Expenses | $377.10M |
| Gross Profit | $155.76M |
| Nonoperating Income/Loss | $6.28M |
| Operating Expenses | $187.64M |
| Depreciation and Amortization | $15.30M |
| Research and Development | $20.46M |
| Other Operating Expenses | $151.88M |
| Operating Income/Loss | -$31.89M |
| Income/Loss From Continuing Operations After Tax | -$24.90M |
| Income/Loss From Continuing Operations Before Tax | -$25.61M |
| Income Tax Expense/Benefit | -$709.00K |
| Income Tax Expense/Benefit, Deferred | -$1.60M |
| Net Income/Loss | -$24.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.92 |
| Diluted Earnings Per Share | -$0.92 |
| Basic Average Shares | 81,554,343 |
| Diluted Average Shares | 81,554,343 |
| Assets | $285.93M |
| Current Assets | $190.67M |
| Inventory | $24.99M |
| Other Current Assets | $165.67M |
| Noncurrent Assets | $95.26M |
| Fixed Assets | $33.69M |
| Other Non-current Assets | $61.58M |
| Liabilities | $103.02M |
| Current Liabilities | $61.45M |
| Accounts Payable | $24.09M |
| Wages | $10.19M |
| Other Current Liabilities | $27.17M |
| Noncurrent Liabilities | $41.57M |
| Equity | $182.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $182.91M |
| Liabilities And Equity | $285.93M |
| Net Cash Flow From Operating Activities | -$1.11M |
| Net Cash Flow From Operating Activities, Continuing | -$1.11M |
| Net Cash Flow From Investing Activities | -$26.15M |
| Net Cash Flow From Investing Activities, Continuing | -$26.15M |
| Net Cash Flow From Financing Activities | -$1.89M |
| Net Cash Flow From Financing Activities, Continuing | -$1.89M |
| Net Cash Flow | -$29.15M |
| Net Cash Flow, Continuing | -$29.15M |
| Comprehensive Income/Loss | -$20.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.97M |
| Other Comprehensive Income/Loss | -$20.97M |
| Other Comprehensive Income/Loss Attributable To Parent | $3.93M |